• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过改变拓扑异构酶I活性对SN-38诱导的拓扑异构酶I DNA交联和SN-38细胞毒性进行热调节。

Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.

作者信息

Katschinski D M, Robins H I

机构信息

Institute of Physiology, Medical University of Lübeck, Germany.

出版信息

Int J Cancer. 1999 Jan 5;80(1):104-9. doi: 10.1002/(sici)1097-0215(19990105)80:1<104::aid-ijc20>3.0.co;2-a.

DOI:10.1002/(sici)1097-0215(19990105)80:1<104::aid-ijc20>3.0.co;2-a
PMID:9935239
Abstract

The effect of different temperatures (37-42.5 degrees C) on SN-38 (the active metabolite of CPT-11) cytotoxicity was examined in the human lung carcinoma cell lines H460 and Calu-6 as well as the murine fibrosarcoma cell line L929. The cytotoxicity of SN-38, determined by MTT cell survival assay, was significantly increased in each cell line in combination with 41.8 degrees C hyperthermia (x60-120 min); the combination of SN-38 with 40.5 degrees C and 42.5 degrees C, however, was unchanged compared to 37 degrees C. Determination of topoisomerase (Topo) I DNA cross-linking in Calu-6 cells and L929 cells after treatment with SN-38 showed the same temperature profile as seen in the cell-survival assays with increased Topo I DNA cross-linking after treatment with the combination of SN-38 and 41.8 degrees C hyperthermia and unchanged Topo I DNA cross-linking at 40.5 degrees C and 42.5 degrees C. To test the hypothesis that increased Topo I DNA cross-linking and SN-38 cytotoxicity at 41.8 degrees C is caused by hyperthermia-modulated changes in Topo I activity, catalytic activity of Topo I extracted from each cell line and of purified human Topo I was determined at 20-42.5 degrees C. Topo I activity was found to be gradually increased with rising temperatures, resulting in significantly higher activity at 41.8 degrees C compared to 37 degrees C; further increase of temperature past 41.8 degrees C decreased Topo I activity back to levels found at 37 degrees C. Our data are used to explain a series of events resulting in hyperthermic enhancement of Topo I DNA cross-linking and SN-38 cytotoxicity in combination with 41.8 degrees C hyperthermia via increased Topo I activity.

摘要

在人肺癌细胞系H460和Calu - 6以及小鼠纤维肉瘤细胞系L929中,研究了不同温度(37 - 42.5摄氏度)对SN - 38(CPT - 11的活性代谢产物)细胞毒性的影响。通过MTT细胞存活试验测定,SN - 38的细胞毒性在每个细胞系中与41.8摄氏度热疗(60 - 120分钟)联合时显著增加;然而,SN - 38与40.5摄氏度和42.5摄氏度联合时,与37摄氏度相比无变化。在用SN - 38处理Calu - 6细胞和L929细胞后,测定拓扑异构酶(Topo)I DNA交联情况,其温度变化情况与细胞存活试验相同,即SN - 38与41.8摄氏度热疗联合处理后Topo I DNA交联增加,而在40.5摄氏度和42.5摄氏度时Topo I DNA交联无变化。为了验证41.8摄氏度时Topo I DNA交联增加和SN - 38细胞毒性增强是由热疗调节的Topo I活性变化所致这一假设,在20 - 42.5摄氏度下测定了从每个细胞系中提取的Topo I以及纯化的人Topo I的催化活性。发现Topo I活性随温度升高而逐渐增加,与37摄氏度相比,在41.8摄氏度时活性显著更高;温度超过41.8摄氏度进一步升高会使Topo I活性降至37摄氏度时的水平。我们的数据用于解释一系列事件,即通过增加Topo I活性,41.8摄氏度热疗联合导致Topo I DNA交联和SN - 38细胞毒性的热增强。

相似文献

1
Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.通过改变拓扑异构酶I活性对SN-38诱导的拓扑异构酶I DNA交联和SN-38细胞毒性进行热调节。
Int J Cancer. 1999 Jan 5;80(1):104-9. doi: 10.1002/(sici)1097-0215(19990105)80:1<104::aid-ijc20>3.0.co;2-a.
2
Evaluation of topoisomerase I catalytic activity as determinant of drug response in human cancer cell lines.评估拓扑异构酶I催化活性作为人类癌细胞系药物反应的决定因素。
Anticancer Res. 1997 Sep-Oct;17(5A):3707-11.
3
Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.拓扑异构酶I抑制剂7-乙基-10-羟基喜树碱与辐射对耐顺铂人小细胞肺癌细胞系的协同作用
Clin Cancer Res. 2002 Jan;8(1):287-92.
4
Sequence of treatment is important in the modification of camptothecin induced cell killing by hyperthermia.在通过热疗改变喜树碱诱导的细胞杀伤作用时,治疗顺序很重要。
Int J Hyperthermia. 1996 Sep-Oct;12(5):663-78; discussion 679-80. doi: 10.3109/02656739609027674.
5
MET increases the sensitivity of gefitinib-resistant cells to SN-38, an active metabolite of irinotecan, by up-regulating the topoisomerase I activity.MET 通过上调拓扑异构酶 I 活性增加了对伊立替康的活性代谢产物 SN-38 的吉非替尼耐药细胞的敏感性。
J Thorac Oncol. 2012 Sep;7(9):1337-44. doi: 10.1097/JTO.0b013e31825cca4c.
6
Homocamptothecin, an E-ring-modified camptothecin, exerts more potent antiproliferative activity than other topoisomerase I inhibitors in human colon cancers obtained from surgery and maintained in vitro under histotypical culture conditions.高喜树碱,一种E环修饰的喜树碱,在从手术获取并在组织典型培养条件下体外维持的人结肠癌中,比其他拓扑异构酶I抑制剂具有更强的抗增殖活性。
Clin Cancer Res. 2000 Apr;6(4):1557-62.
7
Determinants of CPT-11 and SN-38 activities in human lung cancer cells.人肺癌细胞中CPT-11和SN-38活性的决定因素。
Br J Cancer. 1998 Jun;77(12):2171-6. doi: 10.1038/bjc.1998.362.
8
p16INK4 expression is associated with the increased sensitivity of human non-small cell lung cancer cells to DNA topoisomerase I inhibitors.p16INK4表达与人非小细胞肺癌细胞对DNA拓扑异构酶I抑制剂的敏感性增加相关。
Jpn J Cancer Res. 1997 Oct;88(10):1009-16. doi: 10.1111/j.1349-7006.1997.tb00322.x.
9
Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.顺铂与拓扑异构酶I抑制剂NB - 506和SN - 38在人小细胞肺癌细胞中的协同作用。
Cancer Res. 1996 Feb 15;56(4):789-93.
10
Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.对筛选出的对美巴龙(一种DNA拓扑异构酶II催化抑制剂)具有抗性的新型人类白血病细胞系的特性研究。
Cancer Res. 1996 Jun 1;56(11):2573-83.